You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Claims for Patent: 6,184,438


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,184,438
Title: Mutant genes encoding plant ADP-glucose pyrophosphorylase and methods of use
Abstract:The present invention pertains to mutant alleles of the genes encoding the large subunit of AGP-glucose pyrophosphorylase in plants. When present in maize plants, these mutant alleles confer enhanced germination characteristics but without any dimishment of food quality or flavor as compared to plants that express the sh2-R genes. The subject invention also concerns methods for transforming plants with the mutant alleles. The subject invention also concerns plants that have the mutant alleles of the invention incorporated in their genome.
Inventor(s): Hannah; L. Curtis (Gainesville, FL)
Assignee: University of Florida (Gainesville, FL)
Application Number:09/195,966
Patent Claims:1. A polynucleotide molecule that encodes a large subunit of plant ADP-glucose pyrophosphorylase, wherein said polynucleotide comprises the genomic nucleotide sequence of the Shrunken-2 gene of maize, wherein said gene comprises intron 2, and wherein said Shrunken-2 gene comprises a substitution of the wild-type terminal nucleotide of intron 2 of said gene from a G to an A.

2. The polynucleotide according to claim 1, wherein said wild-type genomic nucleotide sequence of said Shrunken-2 gene has the sequence shown in SEQ ID NO. 1, wherein said nucleotide sequence of SEQ ID NO. 1 has been modified by a substitution of the terminal nucleotide of intron 2 from a G to an A.

3. A polynucleotide molecule comprising an intron of the Shrunken-2 gene of maize, wherein said intron is intron 2 of said Shrunken-2 gene and wherein said intron comprises a substitution of the wild-type terminal nucleotide from a G to an A.

4. A plant or plant material each comprising a genome, wherein a polynucleotide of claim 1 as been incorporated into said genome.

5. The plant according to claim 4, wherein said plant is maize.

6. A method for enhancing growth characteristics of a food plant where high sucrose content is desired, without a decrease in food quality of said plant, said method comprising incorporating, a polynucleotide of claim 1 into a plant genome.

7. The method according to claim 6, wherein said plant is maize.

Details for Patent 6,184,438

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2039-02-26
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2039-02-26
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2039-02-26
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.